Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Immune-mediated Thrombotic Thrombocytopenic Purpura”

13 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 13 of 13 results

Not applicableLooking for participantsNCT07513948
What this trial is testing

Daratumumab in Immune-mediated Thrombotic Thrombocytopenic Purpura

Who this might be right for
Thrombotic Thrombocytopenic Purpura, Acquired
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico 40
Not applicableLooking for participantsNCT06928233
What this trial is testing

Association of TNFAIP3 With Immune-mediated TTP

Who this might be right for
Thrombotic Thrombocytopenic Purpura, Acquired
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico 400
Testing effectiveness (Phase 2)Study completedNCT05714969
What this trial is testing

TAK-755 (rADAMTS13) With Little to No Plasma Exchange (PEX) Treatment in Adults With Immune-mediated Thrombotic Thrombocytopenic Purpura (iTTP)

Who this might be right for
Thrombotic Thrombocytopenic Purpura (TTP)
Takeda 29
Testing effectiveness (Phase 2)Ended earlyNCT05502783
What this trial is testing

Using Fostamatinib to Treat Post-Hematopoietic Stem Cell Transplant Immune-mediated Cytopenias

Who this might be right for
Immune Mediated AnemiaImmune Mediated ThrombocytopeniaChronic GVHD
National Heart, Lung, and Blood Institute (NHLBI) 1
Testing effectiveness (Phase 2)WithdrawnNCT05509582
What this trial is testing

Extension Study (Extended Access) of Syk-inhibition Using Fostamatinib to Treat Posttransplant Immune-mediated Cytopenias

Who this might be right for
Immune Mediated AnemiaImmune Mediated ThrombocytopeniaChronic GVHD
National Heart, Lung, and Blood Institute (NHLBI)
Large-scale testing (Phase 3)Study completedNCT05468320
What this trial is testing

Caplacizumab and Immunosuppressive Therapy Without Firstline Therapeutic Plasma Exchange in Adults With Immune-mediated Thrombotic Thrombocytopenic Purpura

Who this might be right for
Thrombotic Thrombocytopenic Purpura
Sanofi 51
Testing effectiveness (Phase 2)Looking for participantsNCT06831058
What this trial is testing

A Pilot Study of Efgartigimod for Immune-mediated Thrombotic Thrombocytopenic Purpura (iTTP)

Who this might be right for
Immune-mediated Thrombotic Thrombocytopenic Purpura
University of Minnesota 15
Early research (Phase 1)Enrolling By InvitationNCT06723106
What this trial is testing

Phase 1b Long-term Extension Trial of RAY121 in Immunological Diseases (RAINBOW-LTE Trial)

Who this might be right for
Antiphospholipid Syndrome (APS)Bullous Pemphigoid (BP)Behçet's Syndrome (BS)+3 more
Chugai Pharmaceutical 144
Early research (Phase 1)Looking for participantsNCT07072247
What this trial is testing

RN1201 Injection in the Treatment of Antibody-Mediated Diseases

Who this might be right for
Refractory Immune-mediated Platelet Transfusion RefractorinessRelapsed or Refractory Immune Thrombocytopenia
The First Affiliated Hospital of Soochow University 9
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07459114
What this trial is testing

TGD001 Treatment in Thrombotic Microangiopathies

Who this might be right for
Thrombotic MicroangiopathiesITP Immune-Mediated Thrombocytopenia
TargED Biopharmaceuticals B.V. 70
Not applicableStudy completedNCT05263193
What this trial is testing

Retrospective Study on Caplacizumab-treated Pediatric Patients With Immune-mediated Thrombocytopenic Purpura (iTTP)

Who this might be right for
Immune-mediated Thrombocytopenic Purpura
Sanofi 4
Early research (Phase 1)Looking for participantsNCT06371417
What this trial is testing

Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial)

Who this might be right for
Antiphospholipid Syndrome (APS)Bullous Pemphigoid (BP)Behçet's Syndrome (BS)+3 more
Chugai Pharmaceutical 144
Not applicableLooking for participantsNCT06291025
What this trial is testing

Efficacy and Safety of Immunosuppression, Caplacizumab and Plasma Infusion Without Therapeutic Plasma Exchange in Immune-mediated Thrombotic Thrombocytopenic Purpura

Who this might be right for
Thrombotic Microangiopathies
University Hospital, Rouen 131